Reply to davison, g. comment on “huijghebaert et al. does trypsin oral spray (viruprotect®/coldzyme®) protect against covid-19 and common colds or induce mutation? caveats in medical device regulations in the european union. int. j. environ. res. public health 2021, 18, 5066”

HIGHLIGHTS

• who: Suzy Huijghebaert and colleagues from the (UNIVERSITY) have published the Article: Reply to Davison, G. Comment on u201cHuijghebaert et al. Does Trypsin Oral Spray (Viruprotectu00ae/ColdZymeu00ae) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int. J. Environ. Res. Public Health 2021, 18, 5066u201d, in the Journal: (JOURNAL) of 30/Dec/2022
• what: In essence, the authors initially interpreted this study as a prophylaxis intervention study, as this was suggested as one of the aims of this study (URTI incidence) and mentioned as the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.